Cite
HARVARD Citation
Cadranel, J. et al. (n.d.). 3087 Characteristics and treatment patterns of ALK+ NSCLC patients who receive second-generation ALK inhibitors: A chart review study. European journal of cancer. pp. S627-S628. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cadranel, J. et al. (n.d.). 3087 Characteristics and treatment patterns of ALK+ NSCLC patients who receive second-generation ALK inhibitors: A chart review study. European journal of cancer. pp. S627-S628. [Online].